NCT07367841

Brief Summary

The goal of this clinical trial is to learn if the FIND HF algorithm detection rates of heart failure during testing are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk in a population identified as at risk of undiagnosed heart failure. The main questions it aims to answer are:

  • Are people who are identified as high risk by the FIND-HF tool more likely to be diagnosed with heart problems during testing than those identified as low risk?
  • Are people identified as high risk by the FIND-HF tool more likely to show signs of heart problems during testing than those identified as low risk?? Researchers will compare patients in the high risk and low risk groups to see if more patients are detected with asymptomatic heart failure in the high risk group compared to the low risk group. Participants will attend one visit at a local clinic where they will undergo an NT proBNP blood test which indicates heart failure and an echocardiogram to evaluate the heart's chambers, valves and overall function to help diagnose various heart conditions.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
475

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Feb 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Feb 2026Oct 2028

First Submitted

Initial submission to the registry

September 30, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

September 30, 2025

Last Update Submit

January 19, 2026

Conditions

Keywords

Artificial IntelligenceData ScienceHealth InequalitiesHeart Failure

Outcome Measures

Primary Outcomes (1)

  • To determine whether detection rates of a composite of asymptomatic LVSD, HFrEF, HFmREF, or HFpEF during diagnostics are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk

    Odds ratio of asymptomatic LVSD, HFrEF, HFmREF, or HFpEF detection rates from intervention in people identified as high HF risk compared with people identified as low HF risk

    Through study completion, an average of 12 months from date of enrolment

Secondary Outcomes (1)

  • To determine if components of composite outcome during diagnostics are higher amongst participants identified as high FIND-HF risk compared to those identified as low risk

    Through study completion, an average of 12 months from date of enrolment

Study Arms (1)

Patients at risk of developing Heart Failure

Patients will attend one visit with a Cardiology specialist Clinical research fellow who will carry out tests to detect Heart Failure

Diagnostic Test: FIND HF algorithm

Interventions

FIND HF algorithmDIAGNOSTIC_TEST

Algorithm developed by the research team to identify patients at risk of heart failure that is currently undetected.

Patients at risk of developing Heart Failure

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients identified at risk of developing Heart Failure by the FIND HF algorithm and are aged 40 and over, living in the Yorkshire area.

You may qualify if:

  • Registered with a doctor practice that uses electronic health system to record patient medical notes Age at enrolment greater or equal to 40 Identified as at risk of developing Heart Failure

You may not qualify if:

  • Registered with a doctor practice that is participating in research studies relating to heart failure screening
  • Known diagnosis of HF
  • On the palliative care register
  • Unable to give written informed consent for participation in the study
  • Unable to adhere to the study requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Chris P. Gale, Yes

    University of Leeds

    STUDY CHAIR

Central Study Contacts

Ramesh Nadarajah, Yes

CONTACT

Catherine Reynolds, Yes

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiovascular Medicine

Study Record Dates

First Submitted

September 30, 2025

First Posted

January 26, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Planning to commercialise algorithm